Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Urvi A Shah

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
JAMA Oncology|May 8, 2020
Cancer and Coronavirus Disease 2019 (COVID-19)-Facing the "C Words"Urvi A Shah
BMJ (Clinical Research Ed.)|September 22, 2020
Emerging immunotherapies in multiple myelomaUrvi A Shah, Sham Mailankody
Best Practice & Research. Clinical Haematology|March 7, 2020
CAR T and CAR NK cells in multiple myeloma: Expanding the targetsUrvi A Shah, Sham Mailankody
JAMA|May 8, 2023
Personal and Planetary Health-The Connection With Dietary ChoicesUrvi A Shah, Gia Merlo
Cancer Journal (Sudbury, Mass.)|May 29, 2019
Multiple Myeloma, Targeting B-Cell Maturation Antigen With Chimeric Antigen Receptor T-CellsUrvi A Shah, Eric L Smith
Current Hematologic Malignancy Reports|August 25, 2021
Targeting BCMA in Multiple MyelomaCarlyn Rose Tan, Urvi A Shah
JAMA Oncology|July 7, 2022
Plant-Based and Ketogenic Diets As Diverging Paths to Address Cancer: A ReviewUrvi A Shah, Neil M Iyengar
Blood Cancer Discovery|August 8, 2025
Food for Thought: Addressing a Research Gap for Dietary Trials in Hematologic MalignanciesAkash Patel, Shireen Kassam, Urvi A Shah
Current Treatment Options in Oncology|June 30, 2017
Immunotherapeutic Approaches to Biliary CancerUrvi A Shah, Amara G Nandikolla, Lakshmi Rajdev
Blood Cancer Discovery|November 12, 2025
The Link between Modifiable Risk Factors and Myeloid Disorders-From Plate to PathogenesisJoshua T Weinreb, Omar Abdel-Wahab, Urvi A Shah
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
JAMA Oncology|May 8, 2020
Cancer and Coronavirus Disease 2019 (COVID-19)-Facing the "C Words"Urvi A Shah
BMJ (Clinical Research Ed.)|September 22, 2020
Emerging immunotherapies in multiple myelomaUrvi A Shah, Sham Mailankody
Best Practice & Research. Clinical Haematology|March 7, 2020
CAR T and CAR NK cells in multiple myeloma: Expanding the targetsUrvi A Shah, Sham Mailankody
JAMA|May 8, 2023
Personal and Planetary Health-The Connection With Dietary ChoicesUrvi A Shah, Gia Merlo
Cancer Journal (Sudbury, Mass.)|May 29, 2019
Multiple Myeloma, Targeting B-Cell Maturation Antigen With Chimeric Antigen Receptor T-CellsUrvi A Shah, Eric L Smith
Current Hematologic Malignancy Reports|August 25, 2021
Targeting BCMA in Multiple MyelomaCarlyn Rose Tan, Urvi A Shah
JAMA Oncology|July 7, 2022
Plant-Based and Ketogenic Diets As Diverging Paths to Address Cancer: A ReviewUrvi A Shah, Neil M Iyengar
Blood Cancer Discovery|August 8, 2025
Food for Thought: Addressing a Research Gap for Dietary Trials in Hematologic MalignanciesAkash Patel, Shireen Kassam, Urvi A Shah
Current Treatment Options in Oncology|June 30, 2017
Immunotherapeutic Approaches to Biliary CancerUrvi A Shah, Amara G Nandikolla, Lakshmi Rajdev
Blood Cancer Discovery|November 12, 2025
The Link between Modifiable Risk Factors and Myeloid Disorders-From Plate to PathogenesisJoshua T Weinreb, Omar Abdel-Wahab, Urvi A Shah
Pageof 8